-
-
-
-
-
-
-
Biogen Announces Reduced Price for Aduhelm to Improve Access For Patients With Early Alzheimer's Disease In The United States
-
-
-
-
-
-
-
Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea
-
-
-
-
-
-
-
Eisai: Transfer of Rights to Anti-Rheumatic Agent Kolbet Tablets 25mg in Japan
-
-
-
-
-
1,174,105 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

